| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |